General Information
Revision date
2022-07-27
Product name
1 of 5
Substance name
AEZS-108
Product Synonyms
Zoptarelin doxorubicin
CAS No.
139570-93-7
REACH No
is
1.2.1 Relevant identified uses
other biochemicals
1.2.2. Uses advised against
not for food or drug use, for laboratory use only
Emergency telephone
+421 2 205 103 85
Icons in SDS
Company Information
company name
BIOSYNTH s.r.o
e-mail address of the competent person responsible for the Safety Data Sheet
customerservice@biosynth-carbosynth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H350, H360
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
1272/2008 Classification of the substance or mixturet
Physical hazards
not classified
Health hazards
Carcinogenicity (Category 1B), H350 Reproductive toxicity (Category 1B), H360 Germ cell mutagenicity 1A
Environmental hazards
not classified
2.2 Label elements
Regulatory List EC1272/08
Hazard pictograms
GHS08
Signal word
Danger Danger
Hazard statements
H340 May cause genetic defects. H350 May cause cancer. H360 May damage fertility or the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P281 Use personal protective equipment as required. P308+P313 IF exposed or concerned: Get medical advice/attention. P501 Dispose of contents / container in accordance with local / regional / national / international regulations.
2.3 Other hazards
Caution! To the best of our knowledge the toxicological properties of this material have not been thoroughly investigated.
2.1 Classification of the substance or mixture
Physical Hazards not classified Health Hazards Carcinogenicity (Category 1B), H350 Reproductive toxicity (Category 1B), H360 Germ cell mutagenicity 1A Enviromental Hazards not classified
